bpc-157 ulcerative colitis phase ii Frontiers Post from Dr. Jones, DC

The limited human data available has not shown significant safety concerns, but long-term human safety data is still being established

The two peptides work on complementary repair pathways, and stacking them is a common protocol in our clinic for patients who need comprehensive recovery rather than isolated tissue repair

BPC-157 (Body Protection Compound) is a synthetic peptide derived from a protective protein originally isolated from human gastric juice

Unlike maintenance dosing at a fixed level, titration involves stepwise dose increases over time to identify minimum effective dose, optimal therapeutic window, or maximum tolerated dose depending on research objectives